SCHEMBL20564003

SCHEMBL20564003

CC(C)(C)OC(=O)N1CCN(c2cncc(N)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 8/20 0.51
MAPT P10636 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
PIK3CA P42336 1/20 0.48
SMARCA2 P51531 1/20 0.47
SMARCA4 P51532 1/20 0.47
PBRM1 Q86U86 1/20 0.47
MEN1 O00255 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAP4K4 O95819 1/20 0.46
CKS1B P61024 1/20 0.45
SKP1 P63208 1/20 0.45
SKP2 Q13309 1/20 0.45
PTPN11 Q06124 1/20 0.44
NR1H2 P55055 1/20 0.44
PDK2 Q15119 1/20 0.44
NAMPT P43490 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12205269 0.90 GPR119 (0.56) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL1686074 0.85 GPR119 (0.52) GPR119MAPTALDH1A1LMNAMEN1
SCHEMBL12225090 0.85 GPR119 (0.52) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL11359349 0.85 GPR119 (0.53) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL32129014 0.85 GPR119 (0.52) GPR119MAPTALDH1A1LMNAMEN1
SCHEMBL23839598 0.85 GPR119 (0.52) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL1704960 0.84 GPR119 (0.51) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL4158823 0.84 GPR119 (0.51) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL15828581 0.84 GPR119 (0.51) GPR119MAPTALDH1A1LMNAPIK3CA
SCHEMBL22944700 0.84 GPR119 (0.51) GPR119MAPTALDH1A1LMNAPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2026-05-12 US disclosed
US-12516055-B2 Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions TRUSTEES OF TUFTS COLLEGE (US) 2026-01-06 US disclosed
EP-4480485-A2 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS University of Houston System (US) 2024-12-25 EP disclosed
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2024-10-03 US disclosed
EP-3968991-B1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIV HOUSTON SYSTEM (US) 2024-07-31 EP disclosed
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2024-06-18 US disclosed
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM 2022-06-23 US disclosed
EP-3968991-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS University of Houston System (US) 2022-03-23 EP disclosed
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2022-03-03 US disclosed
US-11174255-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2021-11-16 US disclosed
WO-2020232190-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM (US) 2020-11-19 WO disclosed
US-20200172536-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2020-06-04 US disclosed
WO-2018213219-A1 PYRIDO[2,3-D]PYRIMIDIN-7ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2018-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174255-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 GPR119 1606/4885MAPT 3070/4885ALDH1A1 3836/4885
US-20200172536-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 GPR119 1606/4885MAPT 3070/4885ALDH1A1 3836/4885
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 GPR119 1371/4885MAPT 3354/4885ALDH1A1 4128/4885
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 GPR119 1371/4885MAPT 3354/4885ALDH1A1 4128/4885
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 GPR119 1371/4885MAPT 3354/4885ALDH1A1 4128/4885
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS RIPK2, RIPK1, RIPK4 GPR119 848/4885MAPT 1839/4885ALDH1A1 4489/4885
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 GPR119 1512/4885MAPT 1893/4885ALDH1A1 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.